Skip to content

Osteopathic Treatment to Alcohol Withdrawal Syndrome

Contribution of Osteopathic Treatment to Alcohol Withdrawal Syndrome in Hospitalized Adult Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03916939
Acronym
OSTEOOL
Enrollment
50
Registered
2019-04-16
Start date
2018-09-26
Completion date
2024-02-13
Last updated
2023-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Withdrawal

Brief summary

The alcohol withdrawal syndrome has a hierarchical symptomatology depending on the severity (minor, moderate or severe). These signs express a state of psychic, behavioral and physical deprivation. The management of withdrawal syndrome involves the establishment of pharmacological and psychosocial interventions. Osteopathy is an exclusively manual practice whose purpose is to overcome the dysfunction of mobility of tissues of the human body. It can be used as a complementary treatment when a specific support is put in place. The purpose of this study is to examine the effectiveness of osteopathy in reducing alcohol withdrawal symptoms in adult patients.

Detailed description

The use of osteopathic techniques for facial equilibration decreases the severity of withdrawal symptoms experienced by patients hospitalized in a weekday hospital.

Interventions

osteopathy treatment

OTHERsimulated osteopathy

simulated osteopathic sessions

Sponsors

Ecole Supérieur d'Ostéopathie
CollaboratorOTHER
Centre Hospitalier Intercommunal Creteil
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Masking description

simulated osteopathy

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

: * Age\> 18 years * Patient hospitalized for a programmed alcohol withdrawal * Patient not abstinent with alcohol before hospitalization * Signed informed consent

Exclusion criteria

: * Minor patient * Patient with an addiction other than alcohol (except tobacco and benzodiazepines) * Previous participation in the OSTEOOL study

Design outcomes

Primary

MeasureTime frameDescription
Cushman score (0 to 27)Day onecomparison between the two groupe of the cushamn socre between 11:30 am and 00:00 pm. questionary for alcohol dependency

Secondary

MeasureTime frameDescription
CIWA Ar test (0 to 67)day 1comparison between the two groupe with this questionary for alcohol withdrawal
cardiac frequency (beat per minute)day 1mesurement of cardiac frequency and compaaison between the two groups
quality sleep scale (0 to 5)day 0comparison between the two groups with sleep score
CIWA Ar (Clinicial Institute Withdrawal Assessment - Alcohol Revised) test (0 to 67)day 0comparison between the two groups with this questionary for alcohol withdrawal
quantity of benzodiazepine (mg per 24 hours)day 3comparison between the two groups of benzodiazepin use
Cushmamn score (0 to 27)day 3comparison between the two groups of the Cushamn score between 11:30 am and 00:00 pm
quantity of benzodiazepine mg per 24 hoursday 2comparison between the two groups of benzodiazepin use

Countries

France

Contacts

Primary Contactcamille JUNG, MD
camille.jung@chicreteil.fr01457022268

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026